These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 26432902

  • 1. The Choice of Hemodialysis Membrane Affects Bisphenol A Levels in Blood.
    Bosch-Panadero E, Mas S, Sanchez-Ospina D, Camarero V, Pérez-Gómez MV, Saez-Calero I, Abaigar P, Ortiz A, Egido J, González-Parra E.
    J Am Soc Nephrol; 2016 May; 27(5):1566-74. PubMed ID: 26432902
    [Abstract] [Full Text] [Related]

  • 2. Influence of dialysis membrane composition on plasma bisphenol A levels during online hemodiafiltration.
    Mas S, Bosch-Panadero E, Abaigar P, Camarero V, Mahillo I, Civantos E, Sanchez-Ospina D, Ruiz-Priego A, Egido J, Ortiz A, González-Parra E.
    PLoS One; 2018 May; 13(3):e0193288. PubMed ID: 29529055
    [Abstract] [Full Text] [Related]

  • 3. Bisphenol A in chronic kidney disease.
    Krieter DH, Canaud B, Lemke HD, Rodriguez A, Morgenroth A, von Appen K, Dragoun GP, Wanner C.
    Artif Organs; 2013 Mar; 37(3):283-90. PubMed ID: 23145999
    [Abstract] [Full Text] [Related]

  • 4. Bisphenol A and chlorinated derivatives of bisphenol A assessment in end stage renal disease patients: Impact of dialysis therapy.
    Cambien G, Dupuis A, Belmouaz M, Bauwens M, Bacle A, Ragot S, Migeot V, Albouy M, Ayraud-Thevenot S.
    Ecotoxicol Environ Saf; 2024 Jan 15; 270():115880. PubMed ID: 38159342
    [Abstract] [Full Text] [Related]

  • 5. Accumulation of bisphenol A in hemodialysis patients.
    Murakami K, Ohashi A, Hori H, Hibiya M, Shoji Y, Kunisaki M, Akita M, Yagi A, Sugiyama K, Shimozato S, Ito K, Takahashi H, Takahashi K, Yamamoto K, Kasugai M, Kawamura N, Nakai S, Hasegawa M, Tomita M, Nabeshima K, Hiki Y, Sugiyama S.
    Blood Purif; 2007 Jan 15; 25(3):290-4. PubMed ID: 17622711
    [Abstract] [Full Text] [Related]

  • 6. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
    Petersen J, Moore RM, Kaczmarek RG, Singh B, Yeh I, Hamburger S, Kankam M.
    Am J Kidney Dis; 1991 Feb 15; 17(2):174-8. PubMed ID: 1992659
    [Abstract] [Full Text] [Related]

  • 7. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
    McCarthy JT, Jenson BM, Squillace DP, Williams AW.
    Am J Kidney Dis; 1997 Apr 15; 29(4):576-83. PubMed ID: 9100048
    [Abstract] [Full Text] [Related]

  • 8. Bisphenol A analogs in patients with chronic kidney disease and dialysis therapy.
    Shen Y, Liu T, Shi Y, Zhuang F, Lu J, Zhu Q, Ding F.
    Ecotoxicol Environ Saf; 2019 Dec 15; 185():109684. PubMed ID: 31541948
    [Abstract] [Full Text] [Related]

  • 9. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K, Krouzzecký A, Polanská K, Mares J, Tomsů M, Bowry SK, Vienken J.
    Hemodial Int; 2006 Apr 15; 10(2):201-8. PubMed ID: 16623675
    [Abstract] [Full Text] [Related]

  • 10. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E, Moczulski D, Grzeszczak W, Gosek K, Augustyn M, Staszewicz P.
    Pol Arch Med Wewn; 1996 Nov 15; 96(5):458-68. PubMed ID: 9091856
    [Abstract] [Full Text] [Related]

  • 11. Toxicological risk assessment of bisphenol a released from dialyzers under simulated-use and exaggerated extraction conditions.
    Badding MA, Vargas JR, Fortney J, Cheng QJ, Ho CH.
    Regul Toxicol Pharmacol; 2020 Dec 15; 118():104787. PubMed ID: 33011233
    [Abstract] [Full Text] [Related]

  • 12. Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse.
    DiRaimondo CR, Pollak VE.
    Am J Kidney Dis; 1989 May 15; 13(5):390-5. PubMed ID: 2655439
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a polynephron dialysis membrane considering new aspects of biocompatibility.
    Martínez-Miguel P, de Sequera P, Albalate M, Medrano D, Sánchez-Villanueva R, Molina A, Sousa F, Benito J, Nuñez J, Vozmediano C, Aragoncillo I, Barril G, Rodríguez-Puyol D, Pérez-García R, López-Ongil S.
    Int J Artif Organs; 2015 Jan 15; 38(1):45-53. PubMed ID: 25633893
    [Abstract] [Full Text] [Related]

  • 14. Higher Serum Bisphenol A Levels in Diabetic Hemodialysis Patients.
    Turgut F, Sungur S, Okur R, Yaprak M, Ozsan M, Ustun I, Gokce C.
    Blood Purif; 2016 Jan 15; 42(1):77-82. PubMed ID: 27193155
    [Abstract] [Full Text] [Related]

  • 15. Lower prevalence of depression in hemodialysis patients who use polysulfone dialyzers.
    Hsu HJ, Chen CK, Wu MS.
    Am J Nephrol; 2009 Jan 15; 29(6):592-7. PubMed ID: 19145074
    [Abstract] [Full Text] [Related]

  • 16. Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia.
    Kiaii M, Djurdjev O, Farah M, Levin A, Jung B, MacRae J.
    JAMA; 2011 Oct 19; 306(15):1679-87. PubMed ID: 22009100
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers].
    Sobaszek-Pitas M, Kopeć J, Krzanowski M, Sułowicz W.
    Przegl Lek; 2014 Oct 19; 71(7):384-8. PubMed ID: 25338334
    [Abstract] [Full Text] [Related]

  • 18. Inflammatory response of a new synthetic dialyzer membrane. A randomised cross-over comparison between polysulfone and helixone.
    Stefoni S, Colì L, Cianciolo G, Donati G, Ruggeri G, Ramazzotti E, Pohlmeier R, Lang D.
    Int J Artif Organs; 2003 Jan 19; 26(1):26-32. PubMed ID: 12602466
    [Abstract] [Full Text] [Related]

  • 19. Lipopolysaccharide-binding protein and bactericidal/permeability-increasing factor during hemodialysis: clinical determinants and role of different membranes.
    Sundaram S, King AJ, Pereira BJ.
    J Am Soc Nephrol; 1997 Mar 19; 8(3):463-70. PubMed ID: 9071715
    [Abstract] [Full Text] [Related]

  • 20. The effect of a membrane dialyzer during hemodialysis on the antioxidant status and lipid peroxidation of patients with end-stage renal disease.
    Ogunro PS, Olujombo FA, Ajala MO, Oshodi TT.
    Saudi J Kidney Dis Transpl; 2014 Nov 19; 25(6):1186-93. PubMed ID: 25394434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.